sales@theinsightpartners.com
+1-646-491-9876 +44-20-8125-4005

Alzheimers Drugs Market Scope And Analysis

  • Report Code : TIPRE00015800
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 215
Buy Now

Alzheimer's Drugs Market Scope and Analysis Report by 2031

Buy Now

Alzheimer's Drugs Market Report Alzheimer's Drugs Market Size and Share Alzheimer's Drugs Market Scope and Analysis

Alzheimer's Drugs Market Report Scope

Report Attribute Details
Market size in 2024 US$ 8.24 Billion
Market Size by 2031 US$ 26.37 Billion
Global CAGR (2025 - 2031) 13.6%
Historical Data 2021-2023
Forecast period 2025-2031
Segments Covered By Drug Class
  • Cholinesterase Inhibitors
  • NMDA Receptor Antagonists
  • Combination Drugs
  • Others
By Cholinesterase Inhibitors
  • Donepezil
  • Rivastigmine
  • Galantamine
By End User
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South korea
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Novartis AG
  • Daiichi Sankyo Co Ltd
  • Johnson Johnson
  • Pfizer Inc
  • Merck Co Inc
  • Biogen Inc
  • Merz Pharma GmbH Co KGaA
  • Eli Lilly and Co
  • Otsuka Pharmaceuticals Co Ltd
  • AbbVie Inc